| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |